Form 4: American Oncology Network's Chief Medical Officer Receives Stock Grant

Stephen Divers, Chief Medical Officer of American Oncology Network, receives 36,000 shares of Class A Common Stock as part of his compensation.

Summary

• Stephen Divers, the Chief Medical Officer of American Oncology Network, Inc. (AONC), has reported a transaction involving the acquisition of 36,000 shares of Class A Common Stock.
• The transaction occurred on July 16, 2024.
• These shares were granted as compensation for his service as Chief Medical Officer.
• 23,400 shares will vest over four years based on a time-based vesting schedule.
• 12,600 shares will vest based on a performance-based vesting schedule.
• Following this transaction, Mr. Divers directly owns 98,470 shares of Class A Common Stock.
• He also indirectly owns 37,499 shares through Divers Investments, LLC and 63,857 shares of Class B Common Stock through a family trust.

Sentiment

Score: 7

Explanation: The document reflects a routine executive compensation event, which is generally viewed neutrally to positively as it aligns management interests with shareholders. The vesting schedule is a positive sign of long-term commitment.

Positives

• The stock grant aligns the Chief Medical Officer's interests with those of the company and its shareholders.
• The vesting schedule, based on both time and performance, incentivizes long-term commitment and achievement of company goals.

Future Outlook

NA

Industry Context

This type of equity compensation is common for executives in publicly traded companies to incentivize performance and align their interests with shareholders.

Comparison to Industry Standards

• Stock grants are a typical component of executive compensation packages in the healthcare industry.
• Companies like McKesson, Cardinal Health, and AmerisourceBergen also utilize stock grants and options to incentivize their leadership teams.
• The vesting schedules described are standard practice to ensure long-term commitment.

Stakeholder Impact

• Shareholders may view the stock grant positively as it incentivizes the Chief Medical Officer to drive company performance.
• Employees may see this as a positive sign of investment in leadership.

Key Dates

Keywords

Form 4, AONC, American Oncology Network, Stephen Divers, Chief Medical Officer, Stock Grant, Beneficial Ownership, Securities Exchange Act